Newsfeeds Archive - Spark Newswire

4 minute read

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD’s Perceived Risks, Knowledge Gaps, Surveys & More

January 15, 2:38 PM

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.

ATAI

4 minute read

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

By Lara Goldstein

October 2, 9:46 AM

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of psychedelics and traditional pharma for the treatment of major depressive disorder (MDD) are out.

ATAI

1 minute read

PharmaTher Is ‘One Step Closer To Being A Ketamine Leader’ Due To FDA Acceptance

By Lara Goldstein

September 27, 2:38 PM

The Food and Durg Administration (FDA) has accepted specialty biopharma company PharmaTher Holdings’ (OTCQB: PHRRF) new drug application for a racemic ketamine product.

PHRRF

2 minute read

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years

By Lara Goldstein

September 12, 4:35 PM

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.

ATAI

4 minute read

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More

By Lara Goldstein

September 11, 9:34 AM

Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification

ATAI

2 minute read

PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application

By Lara Goldstein

September 6, 5:21 PM

Specialty biotech company PharmaTher Holdings (OTCQB: PHRRF) reported it has submitted a priority-original Abbreviated New Drug Application (ANDA) for its proprietary racemic ketamine, KETARX, t

PHRRF

3 minute read

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa’s Magic Pitch & More

By Lara Goldstein

July 24, 5:14 PM

Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal prosecution for possession, use, purchase, cultivation and engaging in practices with “entheogenic plants or plant compounds."

CLABF

2 minute read

PharmaTher’s DMT Patch Shows Positive Outcomes, Investment Toward The Clinical Stage

By Lara Goldstein

July 18, 5:45 PM

PharmaTher Holdings (OTCQB: PHRRF) and the Terasaki Institute for Biomedical Innovation evaluated the former’s novel microneedle patch for the delivery of DMT, and research yielded positive outcomes.

PHRRF